These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22550209)

  • 21. Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility.
    Mereghetti L; Marquet-van der Mee N; Loulergue J; Rolland JC; Audurier A
    Pathol Biol (Paris); 1998 May; 46(5):319-24. PubMed ID: 9769892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tolerance and efficacy of ceftazidime in combination with aztreonam for exacerbations of cystic fibrosis].
    Prévotat A; Leroy S; Perez T; Wallet F; Wallaert B
    Rev Mal Respir; 2010 May; 27(5):449-56. PubMed ID: 20569877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Assael BM
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):967-73. PubMed ID: 22029514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Döring G
    Int J Med Microbiol; 2010 Dec; 300(8):573-7. PubMed ID: 20940108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa.
    van Gennip M; Moser C; Christensen LD; Bjarnsholt T; Calum H; Jensen PØ; Christophersen L; Hougen HP; Ciofu O; Molin S; Givskov M; Høiby N
    J Antimicrob Chemother; 2009 Dec; 64(6):1241-50. PubMed ID: 19815632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pseudomonas aeruginosa and mucoviscidosis].
    Lenoir G
    Rev Pneumol Clin; 1995; 51(3):151-9. PubMed ID: 7569577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nocardia farcinica infection in a patient with cystic fibrosis].
    Beucher J; Belleguic C; Brinchault G; Deneuville E; Donnio PY; Roussey M
    Rev Mal Respir; 2010; 27(1):76-9. PubMed ID: 20146956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on treatment of pulmonary exacerbations in cystic fibrosis.
    Smyth A
    Curr Opin Pulm Med; 2006 Nov; 12(6):440-4. PubMed ID: 17053495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudomonas eradication in cystic fibrosis: who will join the ELITE?
    Smyth AR
    Thorax; 2010 Apr; 65(4):281-2. PubMed ID: 20388748
    [No Abstract]   [Full Text] [Related]  

  • 30. Maintaining normal lung function in children with cystic fibrosis is possible with aggressive treatment regardless of Pseudomonas aeruginosa infections.
    Hansen CR; Gilljam M; Olesen HV; Høiby N; Karpati F; Johansson E; Krantz C; Skov M; Pressler T; Lindblad A
    Acta Paediatr; 2021 Sep; 110(9):2607-2609. PubMed ID: 33866605
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anti-Pseudomonas aeruginosa (Pa) antibiotic therapy and cystic fibrosis].
    Bellon G; Gilly R
    Rev Mal Respir; 1991; 8(2):263. PubMed ID: 1907014
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhaled tobramycin (TOBI).
    Bonsignore CL
    Pediatr Nurs; 1998; 24(3):258-9. PubMed ID: 9987427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of early lung disease in cystic fibrosis: a window of opportunity to eradicate bacteria.
    Starner TD; McCray PB; ;
    Ann Intern Med; 2005 Dec; 143(11):816-22. PubMed ID: 16330793
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pseudomonas aeruginosa infection in cystic fibrosis. The importance of early antibiotic therapy].
    Dutau G; Brémont F
    Rev Mal Respir; 1990; 7(3):183-5. PubMed ID: 2114027
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mucoid Pseudomonas aeruginosa infection in cystic fibrosis].
    Amitani R; Kuze F
    Nihon Rinsho; 1991 Oct; 49(10):2312-6. PubMed ID: 1749087
    [No Abstract]   [Full Text] [Related]  

  • 36. Cystic fibrosis epithelial cell and bacterial binding.
    Engel J; Matthay M
    Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(11):L891. PubMed ID: 24310120
    [No Abstract]   [Full Text] [Related]  

  • 37. Cystic fibrosis epithelial cell and bacterial binding.
    Dosanjh A
    Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(11):L890. PubMed ID: 24310119
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anti Pseudomonas aeruginosa antibiotic therapy in cystic fibrosis (exclusion of macrolides)].
    Sermet-Gaudelus I; Ferroni A; Vrielinck S; Lebourgeois M; Chedevergne F; Lenoir G
    Arch Pediatr; 2006 Oct; 13 Suppl 1():S30-43. PubMed ID: 17370394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aerosolized antibiotic therapy for chronic cystic fibrosis airway infections: continuous or intermittent?
    Lo D; VanDevanter DR; Flume P; Smyth A
    Respir Med; 2011 Dec; 105 Suppl 2():S9-17. PubMed ID: 22208548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystic fibrosis diagnosed in a 38-year-old man with long-standing HIV infection.
    Hoyer HX; Schmid H; Gamarra F; Fischer R; Wörnle M; Huber RM
    Clin Infect Dis; 2004 Aug; 39(3):438-9. PubMed ID: 15307016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.